CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Revance Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 14, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 24, 2024Methods And Systems For Purifying Non-Complexed Botulinum Neurotoxin1
Jan 26, 2022Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect1
Aug 2, 2017Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions1

Top competitors of Revance Therapeutics

Top competitors of Revance Therapeutics based on patent oppositions.